Jazz Pharmaceuticals plc provided earnings guidance for the full year 2024. For the period, the company expected revenues to be in the range of $4,000 million to $4,200 million, net income of $385 million to $530 million and net income per diluted share to be in the range of $5.80 to $7.70.